[Tubulointerstitial nephropathies due to antibiotics].
D058186:Acute Kidney Injury / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002506:Cephalexin / Q000009:adverse effects; D002509:Cephaloridine / Q000009:adverse effects; D002512:Cephalothin / Q000009:adverse effects; D004342:Drug Hypersensitivity; D005839:Gentamicins / Q000009:adverse effects; D006801:Humans; D007612:Kanamycin / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced*; D007684:Kidney Tubules / Q000187:drug effects; D009393:Nephritis / Q000139:chemically induced; D009395:Nephritis, Interstitial / Q000139:chemically induced; D010406:Penicillins / Q000009:adverse effects; D011090:Polyenes / Q000009:adverse effects; D011113:Polymyxins / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D011090:Polyenes; D011113:Polymyxins; D007612:Kanamycin; D002509:Cephaloridine; D002506:Cephalexin; D002512:Cephalothin; D012293:Rifampin
Néphropathies tubulo-interstitielles dues aux antibiotiques